What's new
  • ICMag with help from Landrace Warden and The Vault is running a NEW contest in November! You can check it here. Prizes are seeds & forum premium access. Come join in!

Magic Mushroom Grow Kit?

BudToaster

Well-known member
Veteran
Thank you brother!. 🙏

This morning the cat is totally back to normal!. Yesterday he couldn't walk, he was staggering like a complete drunk and falling over his own limbs. We all thought he was going to die immanently.

I'm thinking that he might have had a TIA?
my last cat was having seizures. she would zoom around the room, then flop down panting and moaning, then get up like nothing had happened, except there was a puddle of urine on the floor.

she had more kitchen sink baths in her last 3 weeks than in her entire life.

i tried dosing her with fenbendazole and ivermectin but it didn't resolve the seizures. she died two weeks ago. 18 years old. last of 3 sister siblings. we're not willing to go through that again - spouse and i are both 76.
 

Hombre del mont

Dr of Stupidity
my last cat was having seizures. she would zoom around the room, then flop down panting and moaning, then get up like nothing had happened, except there was a puddle of urine on the floor.

she had more kitchen sink baths in her last 3 weeks than in her entire life.

i tried dosing her with fenbendazole and ivermectin but it didn't resolve the seizures. she died two weeks ago. 18 years old. last of 3 sister siblings. we're not willing to go through that again - spouse and i are both 76.
My condolences to you both.

Strangely, Wee Wee hadn't wee'd himself.
And neither did he do the circle walking.

He could barely stand and would collapse of he tried to walk. His eyes appeared focused. He was hydrated.

The only other symptoms that I could detect were slight tachycardia and tachypnea.

Initially I thought he had been poisoned, as a neighbour recently lost 5 cats in 2 weeks and we also lost one 2 weeks ago, with similar symptoms, except for the other cat was not uncoordinated until shortly before his death. Yesterday, when all this was happening I wasn't thinking straight and put 2 and 2 together and came up with 5.
 

BudToaster

Well-known member
Veteran
re: shrooms ... dumped my second batch of Amazon - there was a large green contamination in one corner of the bin. looked like algae that i sometimes see outside - on tree bark? somewhere i can't place right now.

Nepal is doing fine. switched to fruiting on 7/1. fresh air exchange several times per day. no pins visible.
 

Hombre del mont

Dr of Stupidity
re: shrooms ... dumped my second batch of Amazon - there was a large green contamination in one corner of the bin. looked like algae that i sometimes see outside - on tree bark? somewhere i can't place right now.

Nepal is doing fine. switched to fruiting on 7/1. fresh air exchange several times per day. no pins visible.
Did you bury it in the ground?

I expected nothing, but now regularly have large shrooms appearing.
 

Loc Dog

Hobbies include "drinkin', smokin' weed, and all k
Veteran
re: shrooms ... dumped my second batch of Amazon - there was a large green contamination in one corner of the bin. looked like algae that i sometimes see outside - on tree bark? somewhere i can't place right now.

Nepal is doing fine. switched to fruiting on 7/1. fresh air exchange several times per day. no pins visible.
Green is trichoderma and spreads very quickly. Most common killer of mushroom grows.
 

moose eater

Well-known member
Minnesota Task Force Recommends Decriminalizing Psilocybin Mushrooms. The state legislature created the Psychedelic Medicine Task Force to assess the potential therapeutic use of psychedelics and recommend appropriate changes to state law based on that assessment. Now, the task force has come out in favor of decriminalizing psilocybin mushrooms and called for a state program to regulate their use in medical treatments.

A majority of task force members favored legalizing the 'shrooms, but they fell short of the supermajority needed to make an official recommendation.

The recommendations are not legally binding but will be submitted to the legislature in a report later this year.

New Hampshire Lawmakers Reject Psychedelic Legalization. The House Health, Human Services and Elderly Affairs Committee on Wednesday killed a bill that would have legalized some psychedelics for medical purposes, House Bill 1693.

The bill would have created six "alternative treatment centers" where patients could purchase and consume psychedelics such as LSD, mescaline, and psilocybin for the treatment of disorders such as PTSD and depression. It would also have allowed for the personal possession of up to two ounces of "usable psychedelics."

But lawmakers from both parties balked.

"The concerns we had with the bill as presented was it was far too broad," Rep. Lucy Weber (D) said.

"I can't tell you how many times I've heard something about a [Journal of the American Medical Association] article comparing psychedelics to existing antidepressants," Rep. Erica Layon (R) said. "But right now, New Hampshire law prohibits a clinical trial from happening in the state with psychedelics because of its status as a controlled substance."

New Jersey Bill Allowing Psilocybin Mushrooms for Therapeutic Use Advances. The Senate Budget Committee on Monday unanimously approved a bill that would legalize and regulate psilocybin treatment centers for people with illnesses or behavioral problems that the drug could treat, Senate Bill 2283.

Companion legislation, Assembly Bill 3852, is also moving. The Assembly Health Committee approved it in June and it awaits a floor vote.

The Senate bill is sponsored by Sen. Nick Scutari (D), who last year sponsored a similar bill that would have allowed adults to possess up to four grams of psilocybin. That provision is not in the current bill.

The bill would create a 15-member commission to study the issue for 18 months and then make recommendations on implementing the bill. Licensing would begin after that period but no later than 24 months after the bill's effective date.

The bill also contains social equity provisions and would give preference to people who lived in a "distressed area" for five of the last 10 years, hire a workforce of whom half live in a "distressed area," or who demonstrate economic need.
 

hfm

Well-known member
Missouri Senate

SB 768

Modifies provisions relating to alternative therapies and treatments, including psilocybin

Sponsor:

Thompson Rehder



LR Number:

4375S.04C

Committee:

Emerging Issues

Last Action:

5/17/2024 - Formal Calendar S Bills for Perfection


Journal Page:



Title:

SCS SB 768

Effective Date:

August 28, 2024







Current Bill Summary

SCS/SB 768 - Under this act, any person who acquires, uses, produces, possesses, transfers, or administers psilocybin for the person's own therapeutic use shall not be subject to state or local criminal or civil penalties if the person: (1) is a Missouri veteran, (2) is 21 years of age or older, (3) suffers from a condition listed in the act, (4) has enrolled or sought to be enrolled in a study regarding the use of psilocybin to treat such conditions, (5) informs the Department of Mental Health that such person plans to acquire, use, produce, possess, transfer, or administer psilocybin under this act, (6) provides the Department with specified documentation and information, (7) ensures the psilocybin is tested in a licensed laboratory, and (8) limits the use of psilocybin to no more than 150 milligrams of psilocybin analyte during any 12-month period. A person who assists another in any of the acts permitted under this act and any laboratory testing psilocybin under this act shall not be subject to state or local criminal or civil penalties.​

Subject to appropriation, the Department shall provide grants totaling $3 million dollars for research on the use and efficacy of psilocybin for the treatment of conditions listed in the act, with such appropriation being made from the Opioid Addiction Treatment and Recovery Fund.

The Department shall prepare annual reports for the Governor, Lieutenant Governor, and the General Assembly on the implementation and outcomes of psilocybin use under this act.

No state agency shall disclose to the federal government or any unauthorized third party the statewide list or any individual information of persons who meet the requirements of this act.

Additionally, this act modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include individuals with life-threatening or severely debilitating conditions or illnesses. Currently, investigational drugs shall not include Schedule I controlled substances. This act repeals that prohibition.

Finally, this act requires the Department, in collaboration with a Missouri university hospital or contract research organizations conducting FDA-approved trials, to conduct a study on the efficacy of using alternative medicine and therapies, including, but not limited to, the use of psilocybin, for the treatment of patients suffering post-traumatic stress disorder, major depressive disorder, substance use disorders, or who require end-of-life care, as described in the act. Such study shall include a study of the use of psilocybin to treat such conditions, as well as a literature review and the submission of various reports. No person participating in the study shall be subject to criminal or civil liability or sanction for participating, except in cases of gross negligence or willful misconduct.

This act is similar to HCS/HB 1830 (2024), HB 1154 (2023), and SB 614 (2023).
SARAH HASKINS

Amendments


No Amendments Found.
 

Latest posts

Latest posts

Top